Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

PHASE3RecruitingINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions

Bronchial Asthma

Interventions

DRUG

Hi-dose iv MgSO4

DRUG

Nebulized budesonide

DRUG

Std-dose iv MgSO4

DRUG

Nebulized normal saline

Trial Locations (1)

RECRUITING

Hamad Medical Corporation, Doha